Welcome: Guest | Site Use Options | Register | Login |

Bacilligen Inc

Bacilligen Inc

Profile last edited on: 2/20/2008
9700 Great Seneca Highway
Rockville, MD 20850
  (301) 217-9525
  info@bacilligen.com
  www.bacilligen.com
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Bacilligen is a biotechnology company focusing on the development of cancer and infectious disease vaccines and therapeutics. Bacilligens lead product is an improved bladder cancer therapy based on rMB, propriety recombinant mycobacteria. Bacilligens other product candidates, which include vaccines for AIDS, cancer, and influenza, are based on a novel bacteriophage capsid system, BVS, for the delivery of nucleic acid therapies and vaccines for cancer and infectious disease. Bacilligens BVS possesses speed and efficiency/cost advantages that make it the system of choice for rapid development and production of custom biological therapies and vaccines, including in personalized medicine and emergency preparedness settings

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Improved Bladder Cancer Therapy With Recombinant BCG

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news



WikiProfile

Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com